What is Exponent Inc's earnings per share (EPS)?

Exponent Inc (EXPO) reported diluted earnings per share of $2.07 for fiscal year 2026. This represents a -1.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Exponent Inc Financials

EXPO

Source SEC Filings (10-K/10-Q) Data as of Apr 3, 2026 Currency USD FYE January

This page shows Exponent Inc (EXPO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EXPO FY2026 2026-05-08

Exponent’s asset-light expert-services model turns steady client work into strong cash generation with little reinvestment demand.

FY2026 looked less like a reinvestment year than a working-capital squeeze: revenue reached $582M, yet operating cash flow slipped to $132M. With receivables at $182M and capex only $9.4M, free-cash-flow pressure appears tied more to slower cash collection and heavy payouts than to a business that suddenly requires more assets to grow.

Across FY2023-FY2026, operating cash flow usually ran ahead of net income, and free-cash-flow margin stayed above 20.0% in 3 of 4 years. That pattern says Exponent’s reported earnings are generally backed by cash and that maintenance investment is light, which is why dividends and buybacks can absorb most excess cash.

The balance sheet still looks liquid rather than stretched, with $222M of cash and a 2.4x current ratio in FY2026. After returning $159M through dividends and buybacks, the bigger balance-sheet change is capital allocation rather than a reinvestment buildout, and no long-term debt was reported.

Financial Health Signals

Financial Health Score 71/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Exponent Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Exponent Inc has an operating margin of 20.6%, meaning the company retains $21 of operating profit per $100 of revenue. This strong profitability earns a score of 88/100, reflecting efficient cost management and pricing power. This is down from 21.4% the prior year.

Growth

Exponent Inc's revenue grew a modest 4.2% year-over-year to $582.0M. This slow but positive growth earns a score of 47/100.

Leverage

Exponent Inc has a moderate D/E ratio of 1.03. This balance of debt and equity financing earns a leverage score of 46/100.

Liquidity

With a current ratio of 2.40, Exponent Inc holds $2.40 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 67/100.

Cash Flow

Exponent Inc converts 21.0% of revenue into free cash flow ($122.3M). This strong cash generation earns a score of 89/100.

Returns

Exponent Inc earns a strong 31.3% return on equity (ROE), meaning it generates $31 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 87/100. This is up from 24.7% the prior year.

Altman Z-Score Safe

8.34

Exponent Inc scores 8.34, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($3.0B) relative to total liabilities ($349.0M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

6/7

Exponent Inc passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.24x

For every $1 of reported earnings, Exponent Inc generates $1.24 in operating cash flow ($131.7M OCF vs $106.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$582.0M

YoY+4.2%

5Y CAGR+6.9%

10Y CAGR+7.0%

Exponent Inc generated $582.0M in revenue in fiscal year 2026. This represents an increase of 4.2% from the prior year.

EBITDA

$129.9M

YoY+0.5%

5Y CAGR+7.2%

10Y CAGR+7.9%

Exponent Inc's EBITDA was $129.9M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 0.5% from the prior year.

Net Income

$106.0M

YoY-2.7%

5Y CAGR+5.2%

10Y CAGR+10.6%

Exponent Inc reported $106.0M in net income in fiscal year 2026. This represents a decrease of 2.7% from the prior year.

EPS (Diluted)

$2.07

YoY-1.9%

5Y CAGR+6.2%

10Y CAGR+4.1%

Exponent Inc earned $2.07 per diluted share (EPS) in fiscal year 2026. This represents a decrease of 1.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$122.3M

YoY-11.1%

5Y CAGR+7.5%

10Y CAGR+8.2%

Exponent Inc generated $122.3M in free cash flow in fiscal year 2026, representing cash available after capex. This represents a decrease of 11.1% from the prior year.

Cash & Debt

$118.6M

YoY-51.6%

5Y CAGR+2.3%

10Y CAGR+1.2%

Exponent Inc held $118.6M in cash against $0 in long-term debt as of fiscal year 2026.

Dividends Per Share

$1.20

YoY+7.1%

5Y CAGR+13.4%

10Y CAGR+14.9%

Exponent Inc paid $1.20 per share in dividends in fiscal year 2026. This represents an increase of 7.1% from the prior year.

Shares Outstanding

49M

YoY-4.4%

5Y CAGR-1.2%

10Y CAGR+14.0%

Exponent Inc had 49M shares outstanding in fiscal year 2026. This represents a decrease of 4.4% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

20.6%

YoY-0.8pp

5Y CAGR+0.2pp

10Y CAGR+1.7pp

Exponent Inc's operating margin was 20.6% in fiscal year 2026, reflecting core business profitability. This is down 0.8 percentage points from the prior year.

Net Margin

18.2%

YoY-1.3pp

5Y CAGR-1.6pp

10Y CAGR+5.2pp

Exponent Inc's net profit margin was 18.2% in fiscal year 2026, showing the share of revenue converted to profit. This is down 1.3 percentage points from the prior year.

Return on Equity

31.3%

YoY+6.6pp

5Y CAGR+5.8pp

10Y CAGR+15.3pp

Exponent Inc's ROE was 31.3% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 6.6 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$97.1M

YoY+1600.4%

5Y CAGR+34.6%

10Y CAGR+14.3%

Exponent Inc spent $97.1M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 1600.4% from the prior year.

Capital Expenditures

$9.4M

YoY+35.3%

5Y CAGR-16.4%

10Y CAGR+4.2%

Exponent Inc invested $9.4M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 35.3% from the prior year.

EXPO Income Statement

Metric	FY26	FY25	FY23	FY22	FY21	FY20
Revenue	$582.0M+4.2%	$558.5M+4.1%	$536.8M+4.6%	$513.3M+10.1%	$466.3M+11.8%	$417.2M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$25.5M+12.3%	$22.7M-7.0%	$24.4M+3.3%	$23.7M+54.8%	$15.3M-25.5%	$20.5M
Operating Income	$119.8M+0.2%	$119.6M+7.4%	$111.3M-21.0%	$140.8M+29.3%	$108.9M+28.0%	$85.1M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$41.3M+7.6%	$38.4M+7.9%	$35.6M+18.9%	$29.9M+21.4%	$24.6M+13.4%	$21.7M
Net Income	$106.0M-2.7%	$109.0M+8.6%	$100.3M-1.9%	$102.3M+1.1%	$101.2M+22.7%	$82.5M
EPS (Diluted)	$2.07-1.9%	$2.11+8.8%	$1.94-1.0%	$1.96+3.2%	$1.90+24.2%	$1.53

Metric	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Revenue	$166.3M+12.8%	$147.4M+0.2%	$147.1M+3.6%	$142.0M-2.4%	$145.5M+6.4%	$136.8M+0.4%	$136.3M-3.0%	$140.5M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$6.2M-7.6%	$6.7M-12.3%	$7.7M+24.6%	$6.1M+22.7%	$5.0M-12.8%	$5.7M+8.2%	$5.3M-12.1%	$6.0M
Operating Income	$41.4M+42.0%	$29.1M+0.4%	$29.0M+69.1%	$17.2M-61.3%	$44.4M+63.0%	$27.3M+5.4%	$25.8M-27.7%	$35.7M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$12.8M+36.7%	$9.3M-11.6%	$10.6M+3.0%	$10.3M-7.6%	$11.1M+43.6%	$7.7M-21.8%	$9.9M-5.4%	$10.5M
Net Income	$29.6M+19.4%	$24.8M-11.7%	$28.0M+5.6%	$26.6M-0.4%	$26.6M+13.0%	$23.6M-9.4%	$26.0M-10.9%	$29.2M
EPS (Diluted)	$0.59	N/A	$0.55+5.8%	$0.520.0%	$0.52	N/A	$0.50-12.3%	$0.57

EXPO Balance Sheet

Metric	FY26	FY25	FY23	FY22	FY21	FY20
Total Assets	$687.4M-9.9%	$763.2M+18.0%	$646.8M+10.2%	$586.7M-14.2%	$683.7M+41.4%	$483.7M
Current Assets	$340.9M-21.2%	$432.8M+14.0%	$379.5M+8.7%	$349.2M-22.9%	$452.8M+54.3%	$293.4M
Cash & Equivalents	$118.6M-51.6%	$245.1M+31.0%	$187.2M+15.9%	$161.5M-45.8%	$297.7M+181.9%	$105.6M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$197.3M+18.3%	$166.8M-0.3%	$167.4M-1.6%	$170.1M+21.6%	$139.9M+9.9%	$127.2M
Goodwill	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M
Total Liabilities	$349.0M+8.5%	$321.8M+10.7%	$290.7M+9.3%	$265.9M-0.3%	$266.7M+66.5%	$160.2M
Current Liabilities	$142.2M+9.2%	$130.3M-19.5%	$161.9M+1.8%	$159.0M+4.0%	$153.0M+98.4%	$77.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$338.3M-23.4%	$441.4M+24.0%	$356.1M+11.0%	$320.8M-23.1%	$417.1M+28.9%	$323.5M
Retained Earnings	$682.0M+7.4%	$635.0M+10.6%	$574.1M+8.6%	$528.8M+10.5%	$478.4M+20.9%	$395.6M

Metric	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Total Assets	$687.4M-11.6%	$777.5M+2.1%	$761.4M+0.3%	$759.4M-0.5%	$763.2M-1.8%	$777.3M+4.5%	$744.1M+4.9%	$709.2M
Current Assets	$340.9M-20.3%	$427.6M+2.6%	$416.8M-2.1%	$425.7M-1.7%	$432.8M-3.2%	$446.9M+8.3%	$412.6M+5.4%	$391.3M
Cash & Equivalents	$118.6M-46.6%	$221.9M+7.0%	$207.4M-10.5%	$231.8M-5.4%	$245.1M-5.3%	$258.9M+17.8%	$219.7M+8.1%	$203.3M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$197.3M+8.7%	$181.5M-0.3%	$182.0M+6.4%	$171.0M+2.5%	$166.8M+3.3%	$161.4M-4.3%	$168.6M+1.7%	$165.9M
Goodwill	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M
Total Liabilities	$349.0M-9.8%	$387.2M+8.0%	$358.6M+8.1%	$331.7M+3.1%	$321.8M-9.6%	$356.2M+6.7%	$333.8M+5.6%	$316.0M
Current Liabilities	$142.2M-20.1%	$178.0M+15.0%	$154.8M+14.7%	$135.0M+3.6%	$130.3M-20.2%	$163.2M+18.5%	$137.7M+4.5%	$131.8M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$338.3M-13.3%	$390.3M-3.1%	$402.9M-5.8%	$427.8M-3.1%	$441.4M+4.8%	$421.1M+2.6%	$410.3M+4.3%	$393.2M
Retained Earnings	$682.0M+2.0%	$668.4M+1.5%	$658.8M+2.0%	$646.0M+1.7%	$635.0M+1.7%	$624.2M+1.5%	$615.0M+1.9%	$603.4M

EXPO Cash Flow Statement

Metric	FY26	FY25	FY23	FY22	FY21	FY20
Operating Cash Flow	$131.7M-8.9%	$144.5M+13.5%	$127.4M+35.8%	$93.8M-24.7%	$124.6M+15.3%	$108.1M
Capital Expenditures	$9.4M+35.3%	$6.9M-57.6%	$16.4M+35.8%	$12.0M+76.4%	$6.8M-70.4%	$23.0M
Free Cash Flow	$122.3M-11.1%	$137.6M+24.0%	$111.0M+35.8%	$81.8M-30.6%	$117.7M+38.5%	$85.0M
Investing Cash Flow	-$9.4M-35.3%	-$6.9M+57.6%	-$16.4M-35.8%	-$12.0M-131.5%	$38.2M+794.3%	$4.3M
Financing Cash Flow	-$160.4M-146.4%	-$65.1M+24.3%	-$86.0M+60.2%	-$216.0M-244.2%	-$62.8M+1.0%	-$63.4M
Dividends Paid	$61.5M+5.7%	$58.2M+7.7%	$54.0M+9.8%	$49.2M+14.0%	$43.2M+28.9%	$33.5M
Share Buybacks	$97.1M+1600.4%	$5.7M-76.4%	$24.2M-84.5%	$155.9M+2126.5%	$7.0M-68.1%	$22.0M

Metric	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Operating Cash Flow	-$975K-101.8%	$55.6M+70.2%	$32.7M-9.9%	$36.2M+398.0%	$7.3M-87.0%	$56.1M+88.6%	$29.7M-38.5%	$48.3M
Capital Expenditures	$2.5M-8.7%	$2.7M+0.4%	$2.7M+17.6%	$2.3M+29.6%	$1.8M-32.5%	$2.6M+51.5%	$1.7M+49.6%	$1.1M
Free Cash Flow	-$3.4M-106.5%	$52.9M+76.5%	$30.0M-11.7%	$33.9M+515.0%	$5.5M-89.7%	$53.5M+90.9%	$28.0M-40.7%	$47.2M
Investing Cash Flow	-$2.5M+8.7%	-$2.7M-0.4%	-$2.7M-17.6%	-$2.3M-29.6%	-$1.8M+32.5%	-$2.6M-51.5%	-$1.7M-49.6%	-$1.1M
Financing Cash Flow	-$99.7M-159.6%	-$38.4M+29.5%	-$54.5M-14.8%	-$47.5M-136.8%	-$20.0M-62.7%	-$12.3M+4.9%	-$13.0M-2.8%	-$12.6M
Dividends Paid	$16.6M+11.4%	$14.9M-1.2%	$15.1M-1.0%	$15.2M-7.0%	$16.4M+15.0%	$14.2M+0.1%	$14.2M+0.1%	$14.2M
Share Buybacks	$78.8M+223.0%	$24.4M-39.1%	$40.0M	N/A	N/A	$1K+200.0%	-$1K-100.4%	$244K

EXPO Financial Ratios

Metric	FY26	FY25	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	20.6%-0.8pp	21.4%+0.7pp	20.7%-6.7pp	27.4%+4.1pp	23.4%+3.0pp	20.4%
Net Margin	18.2%-1.3pp	19.5%+0.8pp	18.7%-1.2pp	19.9%-1.8pp	21.7%+1.9pp	19.8%
Return on Equity	31.3%+6.6pp	24.7%-3.5pp	28.2%-3.7pp	31.9%+7.6pp	24.3%-1.2pp	25.5%
Return on Assets	15.4%+1.1pp	14.3%-1.2pp	15.5%-1.9pp	17.4%+2.6pp	14.8%-2.3pp	17.1%
Current Ratio	2.40-0.9	3.32+1.0	2.34+0.1	2.20-0.8	2.96-0.8	3.81
Debt-to-Equity	1.03+0.3	0.73-0.1	0.82-0.0	0.83+0.2	0.64+0.1	0.50
FCF Margin	21.0%-3.6pp	24.6%+4.0pp	20.7%+4.8pp	15.9%-9.3pp	25.3%+4.9pp	20.4%

Metric	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	24.9%+5.1pp	19.8%+0.0pp	19.7%+7.6pp	12.1%-18.4pp	30.5%+10.6pp	19.9%+1.0pp	19.0%-6.5pp	25.4%
Net Margin	17.8%+1.0pp	16.8%-2.3pp	19.1%+0.4pp	18.7%+0.4pp	18.3%+1.1pp	17.3%-1.9pp	19.1%-1.7pp	20.8%
Return on Equity	8.7%+2.4pp	6.3%-0.6pp	7.0%+0.7pp	6.2%+0.2pp	6.0%+0.4pp	5.6%-0.8pp	6.3%-1.1pp	7.4%
Return on Assets	4.3%+1.1pp	3.2%-0.5pp	3.7%+0.2pp	3.5%+0.0pp	3.5%+0.5pp	3.0%-0.5pp	3.5%-0.6pp	4.1%
Current Ratio	2.400.0	2.40-0.3	2.69-0.5	3.15-0.2	3.32+0.6	2.74-0.3	3.00+0.0	2.97
Debt-to-Equity	1.03+0.0	0.99+0.1	0.89+0.1	0.78+0.0	0.73-0.1	0.85+0.0	0.81+0.0	0.80
FCF Margin	-2.1%-37.9pp	35.9%+15.5pp	20.4%-3.5pp	23.9%+20.1pp	3.8%-35.3pp	39.1%+18.5pp	20.5%-13.0pp	33.6%

Similar Companies

Tutor Perini TPC

$3.9B

Argan Inc AGX

$9.6B

Everus Constr Group ECG

$7.1B

Myr Group Inc Del MYRG

$6.7B

Arcosa Inc ACA

$7.1B

Frequently Asked Questions

What is Exponent Inc's annual revenue?

Exponent Inc (EXPO) reported $582.0M in total revenue for fiscal year 2026. This represents a 4.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Exponent Inc's revenue growing?

Exponent Inc (EXPO) revenue grew by 4.2% year-over-year, from $558.5M to $582.0M in fiscal year 2026.

Is Exponent Inc profitable?

Yes, Exponent Inc (EXPO) reported a net income of $106.0M in fiscal year 2026, with a net profit margin of 18.2%.

What is Exponent Inc's EBITDA?

Exponent Inc (EXPO) had EBITDA of $129.9M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

What is Exponent Inc's operating margin?

Exponent Inc (EXPO) had an operating margin of 20.6% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Exponent Inc's net profit margin?

Exponent Inc (EXPO) had a net profit margin of 18.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Does Exponent Inc pay dividends?

Yes, Exponent Inc (EXPO) paid $1.20 per share in dividends during fiscal year 2026.

What is Exponent Inc's return on equity (ROE)?

Exponent Inc (EXPO) has a return on equity of 31.3% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Exponent Inc's free cash flow?

Exponent Inc (EXPO) generated $122.3M in free cash flow during fiscal year 2026. This represents a -11.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Exponent Inc's operating cash flow?

Exponent Inc (EXPO) generated $131.7M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Exponent Inc's total assets?

Exponent Inc (EXPO) had $687.4M in total assets as of fiscal year 2026, including both current and long-term assets.

What are Exponent Inc's capital expenditures?

Exponent Inc (EXPO) invested $9.4M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Does Exponent Inc buy back shares?

Yes, Exponent Inc (EXPO) spent $97.1M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

How many shares does Exponent Inc have outstanding?

Exponent Inc (EXPO) had 49M shares outstanding as of fiscal year 2026.

What is Exponent Inc's current ratio?

Exponent Inc (EXPO) had a current ratio of 2.40 as of fiscal year 2026, which is generally considered healthy.

What is Exponent Inc's debt-to-equity ratio?

Exponent Inc (EXPO) had a debt-to-equity ratio of 1.03 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Exponent Inc's return on assets (ROA)?

Exponent Inc (EXPO) had a return on assets of 15.4% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Exponent Inc's Altman Z-Score?

Exponent Inc (EXPO) has an Altman Z-Score of 8.34, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Exponent Inc's Piotroski F-Score?

Exponent Inc (EXPO) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Exponent Inc's earnings high quality?

Exponent Inc (EXPO) has an earnings quality ratio of 1.24x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Exponent Inc?

Exponent Inc (EXPO) scores 71 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.